Updates to the World Health Organization's Recommendations for the Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants
about
What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisChildren who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysisAsking the right questions: developing evidence-based strategies for treating HIV in women and childrenHIV-1 Genetic Variability and Clinical ImplicationsAnalysis of HIV early infant diagnosis data to estimate rates of perinatal HIV transmission in ZambiaHair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeedingFeasibility and safety of setting up a donor breastmilk bank in a neonatal prem unit in a resource limited setting: An observational, longitudinal cohort studyHIV-1 drug mutations in children from northern TanzaniaComparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens.Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study.The cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.Pregnancy and sexually transmitted viral infections.Assessment on the knowledge and reported practices of women on maternal and child health in rural Sierra Leone: a cross-sectional surveyEffect of nutritional supplementation of breastfeeding HIV positive mothers on maternal and child health: findings from a randomized controlled clinical trialHealth facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL studyKnowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child-transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional studyPrevention of mother-to-child HIV transmission in resource-limited settings: assessment of 99 Viramune Donation Programmes in 34 countries, 2000-2011.Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancyRisk of HIV and associated factors among infants born to HIV positive women in Amhara region, Ethiopia: a facility based retrospective study.Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infantsPharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection.The epidemiological impact of HIV antiretroviral therapy on malaria in children.The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research.The quality of clinical maternal and neonatal healthcare - a strategy for identifying 'routine care signal functions'Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population.A comparative analysis of national HIV policies in six African countries with generalized epidemicsBrief Report: HIV Testing Among Pregnant Women Who Attend Antenatal Care in Malawi.The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double-blind, placebo-controlled trial in Uganda.Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical TrialCost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in ZimbabweWHO option B+: early experience of antiretroviral therapy sequencing after cessation of breastfeeding and risk of dermatologic toxicity.Consideration of postpartum management in HIV-positive Haitian women: an analysis of CD4 decline, mortality, and follow-up after delivery.A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS.Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.HLA-G 14 bp deletion/insertion polymorphism and mother-to-child transmission of HIV.Postnatal cytomegalovirus exposure in infants of antiretroviral-treated and untreated HIV-infected mothers.
P2860
Q28478769-2285D8EF-7D8A-465C-915E-0CB03AF3E311Q28731813-5FB5329D-483A-49A3-A427-53F4062E7E38Q28743488-EB6C1ABC-2B60-434F-AE79-041BF0CFF0A1Q30352010-705C577E-E912-4E84-8134-0608CD0640CBQ30558708-DB1E5C52-EE13-4164-A2CC-0F5D1EFB8CC6Q30679524-73FE2F53-F2A0-4CF9-89C2-ABBE4196F575Q31014547-85FCA904-EDE6-4FB4-A8DE-A95DC5176DAFQ33746054-BF432A94-C778-4A77-A92A-8D95EF133E85Q33763923-8B6EC358-DDAD-4C18-BD2A-30E438BBB32FQ33776923-7C781DA6-266F-4492-ABB9-EE86B98462F5Q33940190-733ED28D-6D27-4639-87A9-2E5A2DAC85EAQ34027261-137A9F4D-9A23-4972-B4F4-CA35CBD2ADA6Q34105287-CDEAA85B-E8C9-43F9-9D67-9894CA225DB3Q34109075-2CA67333-F55E-44A1-A580-C664EE1A72EBQ34140273-C2CCF5EC-E6F3-4E50-A095-B860084ABD72Q34556273-39FEFBEF-E64C-41B9-AA3C-DDE5EE5C63ACQ34722182-599A2B23-5763-45CF-B4DE-EC62C4AB0392Q34758192-881DC660-F90C-491B-8B21-11DB7E0689D8Q34898415-4F4D4534-5533-494C-9D4C-90D39B7CFC01Q35084426-01473FED-1CBC-4F76-8839-78EC2F6C19C9Q35102702-E3E3142F-A656-4EFD-87AB-7F6A83F3DE7FQ35347170-593D63F9-472F-4D78-AF5D-3F56A91CD8C1Q35357681-A624AE57-5E2C-42B6-9B74-575AB233DAD7Q35432355-E48577F0-58FA-4D3F-8D65-B8EDE0F126A4Q35598505-F49CEE60-3A8D-441C-9E45-360472CD9F7DQ35738687-946109B9-24E7-4EEE-9ACF-626B0FA93A70Q35815103-01376B8F-2B12-47B7-8E9A-102EB56F5538Q35850394-78E61BCF-A015-4B67-B2E2-1511D7CF58F7Q36059796-968F8B4C-123C-4EFE-B4AA-F847AE7FDA03Q36306986-D084E9C9-1C1E-4920-92FA-7ADAEBD8BF3DQ36517778-CEA7DC28-FE37-4474-B1E5-B3C091754595Q37083642-2F53D400-954D-4E8E-A2A9-FAD9C3E9622AQ37156384-8E5928A4-E1D8-4EBB-A56F-A039B8022A8BQ37465679-43EC7911-C127-44E9-B6D8-2C355B711128Q37503621-59B87F47-3879-4A99-B03E-37990698D6EBQ37632043-3725D588-085A-41D1-AB83-6C7EA28DF3CBQ37644893-5B7F17F2-DF38-42BC-B959-261108B03384
P2860
Updates to the World Health Organization's Recommendations for the Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Updates to the World Health Or ...... nting HIV Infection in Infants
@ast
Updates to the World Health Or ...... nting HIV Infection in Infants
@en
type
label
Updates to the World Health Or ...... nting HIV Infection in Infants
@ast
Updates to the World Health Or ...... nting HIV Infection in Infants
@en
prefLabel
Updates to the World Health Or ...... nting HIV Infection in Infants
@ast
Updates to the World Health Or ...... nting HIV Infection in Infants
@en
P2093
P2860
P1476
Updates to the World Health Or ...... nting HIV Infection in Infants
@en
P2093
Christopher M Bositis
Devang M Patel
Ignace Gashongore
P2860
P304
P577
2010-01-01T00:00:00Z